Advertisement

Topics

PhaseBio nets $40mm through public stock sale

15:40 EDT 16 Apr 2019 | Elsevier Business Intelligence

PhaseBio Pharmaceuticals Inc. (orphan disease drug development) netted $40mm through the public sale of 4.2mm common shares a...

Original Article: PhaseBio nets $40mm through public stock sale

NEXT ARTICLE

More From BioPortfolio on "PhaseBio nets $40mm through public stock sale"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...